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Summary Benzo(a)pyrene and benzene are human carcinogens. The metabolic activation of these compounds into ultimate mutagenic and
carcinogenic metabolites is prerequisite for their carcinogenic effects. In this report. the mutagenicity and carcinogenicity of hydroquinones of
benzo(a)pyrene and benzene was investigated to address two important questions: (1) do hydroquinones contribute to benzo(a)pyrene and
benzene carcinogenicity: and (2) how safe is it to increase the levels of NAD(P)H:quinone oxidoreductase 1 (NO01). a key enzyme in the
generation of hydroquinone. The supFtRNA of the plasmid pSP189 was used as the mutational target in a cell-free and Chinese hamster
ovary (CHO) cell system to study hydroquinone mutagenicity. RNA and protein-free pSP189 DNA was incubated in a cell-free system with
benzo(a)pyrene-3,6-quinone and purified NO01 or with benzoquinone hydroquinone to generate adducted pSP189 DNA. The adducted
pSP189 DNA was transfected in human embryonic kidney cells Ad293. In the CHO cell system, monolayer cultures of CHO cells and CHO
cells overexpressing NOO1 or P450 reductase were transfected with pSP189 vector DNA, treated with benzo(a)pyrene-3.6-quinone. The
adducted and replicated pSP189 DNA was rescued from transfected Ad293 (cell-free system) and CHO cells (CHO cell system). digested
with the restriction enzyme Dpnl to remove unreplicated DNA followed by transformation in Eschenchia coliMBM7070. The mutant colonies
[white/pale blue on 5-bromo-4-chloro-3-indolyl 5-D-galactoside/isopropyl >-D-thiogalactoside (X-gaVIPTG) plates] were selected. regrown and
analysed by DNA sequencing. Mutagenesis experiments demonstrated that hydroquinones cause sequence-specific frameshift mutations
involving deletion of a single cytosine from the DNA sequence 5'-172-CCCCC176-3' or a single guanosine from the complementary strand
sequence 5'-GGGGG-3' in the supFtRNA gene. This mutation was specific to the hydroquinones, as it was not observed with quinones and
other components of the redox cycling (semiquinones and reactive oxygen species). Exposure of BALBc/3T3 cells to hydroquinones resulted
in cellular transformation leading to the loss of contact inhibition and regulation of cell growth. The transformation efficiency of BALBc/3T3
cells exposed to hydroquinones was significantly increased by the tumour promoter 12-Otetradecanoylphorbol-13-acetate (TPA), indicating
that hydroquinones are excellent initiators that require additional co-carcinogens or promoters to exert an effect. The hydroquinone + TPA as
well as hydroquinone-transformed BALBcI3T3 cells. when injected s.c. in severe combined immunodeficient (SCID) mice. produced tumours
at 10000 frequency. These results establish that hydroquinones lead to mutagenicity and carcinogenicity.
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Exposure to environmental chemical carcinogens [e.g.
benzoa)pxyrene and benzene] is known to cause numerous human
cancers (Harm's. 1991 ). Benzo a)pyrene and benzene are procar-
cinogens that require metabolic activation to exert their mutagenic
and carcinogenic effects (Gelboin. 1980). Benzoa)pxyrene under-
coes oxidatix-e metabolism to renerate more than 25 metabolites
IGelboin. 1980). The most studied metabolite ofbenzowapyrene is
benzo a)px-rene-7.8-dihx drodiol-9.10-epoxide BPDE). BPDE is
know-n to bind w-ith DNA and cause G-sT transversions. leading to
carcinogenicitv- (Jernstrom and Graslund. 1994). These obserna-
tions. although establishing an important role for BPDE in
benzo(a)pyrene carcinogenicity. also raised interesting questions
regarding the role of metabolites other than BPDE in
benzo4a)pyrene mutagenicity and carcinogenicitx. In addition. the
metabolites of benzene responsible for benzene carcinogenicitV
remain to be identified. Oxidative metabolism of benzo(a pyrene
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and benzene generates a common class of compounds. quinones
(Gelboin. 1980: O'Brien. 1991: Hiraku and Kauwanishi. 1996). In
addition to the benzowapyrene quinones and benzoquinones. a
xariety of other quinones (e.g. naphthoquinones. tocopherol) are
highlx abundant in nature (Chesis et al. 1984). Therefore. human
exposure to quinones is extensive. The quinones are highlv reactive
molecules that undergo further metabolism by one-step two-elec-
tron reduction [catalx-sed bv NAhADP)H:quinone oxidoreductasel
(NQO )] or tu-o-step one-electron reduction [catalx-sed by
NADPH:cvtochrome P450 reductase (P450 reductase)] (O'Bnren.
1991: Monks et al. 1992: Joseph et al. 1994: Talalay et al. 1995).
The difference betu-een the tu-o-electron and one-electron reduc-
tion pathways for quinones is that the latter. and not the former.
pathu-av aenerates semiquinones and reactixe oxygen species of
known toXicitv and mutagenicitv (O'Brien. 1991: Monks et al.
1992: Joseph et al. 1994: Talalay et al. 1995). For this reason the
tu-o-electron reduction pathw-av of consversion of quinones to
hydroquinones by NQO1 is considered protectis e to the cells
against the one-electron reduction pathway cons-erting quinones to
semiquinones and then to the hydroquinones. In fact. NQO1 has
been show-n to compete with P450 reductase for metabolic conver-
sion of quinones to hydroquinone. resulting in protection to the
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cells (Joseph and Jaiswal. 1994). The above observations have led
to the discovery of natural and synthetic inducers of the NQOI
gene. to increase the chemoprotective capacity of cells against
exposure to quinones and related compounds (Prochaska et al.
1992; Zhang et al. 1992).
In this report. we have investigated the mutagenicity and
carcinogenicity of hydroquinones to address two important ques-
tions: (1) do hydroquinones contribute to benzo(a)pyrene and
benzene carcinogenicity: and (2) how safe is it to increase the levels
of quinone detoxifying enzyme (NQO1). which catalyses conver-
sion of quinones to hydroquinones. The various results demon-
strated that hydroquinones specifically caused deletion of a single
cytosine from the DNA sequence 5'-CCCCC-3' ofthe supF tRNA
gene. Hydroquinones also transformed BALBc/3T3 cells. The
frequency ofhydroquinone-induced transformation ofBALBc/3T3
cells was significantly increased by tumour-promoting agent
12-0-tetradec anoylphorbol-13-acetate (TPA). The hydroquinone-
and hydroquinone + TPA-transformed BALBc/3T3 cells. when
injected s.c. in SCID mice, produced fast-growing tumours.
MATERIALS AND METHODS
Materials
The shuttle vectorpSP189carrying the mutational targetsupFtRNA
gene was a generous gift from Dr Michael Seidman (Oncorphami.
Gaithersburg. MD. USA). The Chinese hamster ovary cells (CHO-
DHFR-). human embryonic kidney cells Ad293 and mouse fibrob-
last (BALBc/3T3) cells were obtained from ATCC. Rockville. MD.
USA. The cDNA encoding P450 reductase was a kind gift from
Dr Frank Gonzalez. NCI. Bedtsda. MD. USA. Ingedients of the
media used to grow the bacterial cells and to select the mutants were
purchased from Difco Laboratories (Detroit MI. USA). All other
reagents used in the experiments were ofthe highest purity available
commercially. The DNA sequencing kit version 2.0 was purchased
from USB Corporation. Cleveland. OH. USA. BP-3.6-quinone was
purchased from theChemicalCarcigenRepository ofthe National
Cancer Institute (Kansas City. MO. USA). Benzoquinone hydro-
quinone (HQ) was purchased from Sigma. St. Louis. MO. USA.
SCID mice were obtained from the Animal Facility at Fox Chase
CancerCenter, Philadelphia PA. USA.
Purified human and rat NQOl were obtained as a gift from Dr
David Ross. University ofColorado. Boulder. CO. USA. One unit
of purified NQO1 activity is the amount of NQO1 protein that
catalyses reduction of 1 gmol of2,6-dichlorophenolindophenol in
1 min (Joseph and Jaiswal. 1994).
Mutational analysis
Cell-free system
The supFtRNA ofthe plasmid pSP189 was used as the mutational
target to study hydroquinone mutagenicity by procedures as
described previously (Kraemer and Seidman. 1989; Paris and
Seidman. 1992). Briefly. RNA and protein-free pSP189 DNA was
prepared using the Qiagen plasmid preparation kit by the proce-
dure as described in the manufacturer's instruction manual. The
DNA was further cleaned with phenol-chloroform and ethanol
precipitation by standard procedures (Sambrook et al. 1989). An
aliquot of 10 gg of pSP189 DNA was incubated with 15 gM
benzo(a)pyrene-3.6-quinone in the absence and presence of ten
units ofpurified human or rat NQOI activity under the conditions
as described by us previously to generate BP-3.6-HQ and DNA
adduct formation (Joseph and Jaiswal. 1994). In related experi-
ments. the BP-3.6-Q was replaced with 15 gm hydroquinone (HQ)
in the absence of NQO1 enzyme. The adducted pSP189 DNA
was isolated and purified by the phenol-chloroform extraction and
ethanol precipitation procedure and used to transfect human
embryonic kidney cells Ad293 by the calcium phosphate precipita-
tionprocedure (Sambrook et al. 1989). pSP189 DNA rescued from
the transfected Ad293 cells was digested with the restriction
enzyme Dpnl to remove unreplicated DNA and was used to trans-
form competent E scherichia coli strain MBM7070 by electro-
poration using a Gene Pulser apparatus (Bio Rad. Hercules. CA)
set at 2.5 kV. 25 gF and 200 Q according to the manufacturer's
instructions. Mutants growing as white or pale blue colonies on
LB plates containing 50 jgc ml-' ampicillin. 20jg¢ ml-' 5-bromo-
4-chloro-3-indolyl P-D-galactoside (X-gal) and 100 jg ml-'
isopropyl >-E-thiogalactoside (IPTG) were selected and regrown
on fresh plates. The plasmid DNA from the mutants was isolated
and purified by the alkaline lysis procedure (Sambrook et al.
1989). The SupF tRNA region of pSP189 isolated from mutant
colonies was sequenced using the sequenase version 2.0 DNA
sequencing kit. It may be noteworthy that every mutation was
selected from a single transformation to avoid sibling formation.
Chinese hamster ovary (CHO) cell system
DevelopmentofCHOcellspermanentlyexpressinghigh
levels ofmicrosomal P450 reductase orcytosolic NH01
ac.vity. Human cDNAs encoding cytosolic NQOI and
microsomal P450 reductase have been cloned and sequenced
(Jaiswal et al. 1988: Yamano et al. 1989). Human cDNAs for
NQOI and P450 reductase were separately subcloned in pED6
vector to generate pED6-NQOl and pED6-P450 reductase
plasmids (Kaufman et al. 1991). The CHO cells were transfected
with pED6-P450 reductase or pED6-NQOl recombinant plasmid
and selected in the presence of increasing concentrations of
methotrexate by procedures as described previously (Kaufman et
al. 1991). The selected clones were analysed for NQO1 and P450
reductase activities by procedures as described previously (Joseph
and Jaiswal. 1994). The clone designated as CHO (NQOI)
selected for overexpression of cDNA-derived NQOI expressed
1367-fold higher levels of NQO1 activity than the untransfected/
vector transfected control CHO cells. Similarly. the selected clone
CHO (P450 reductase) expressed 34-fold higher levels of cDNA-
derived microsomal P450 reductase as compared with control
CHO cells. The control CHO (wild type). CHO (NQOl ) and CHO
(P450 reductase) were used in hydroquinone mutagenesis studies.
Monolayers ofCHO (wild type). CHO (NQOO1) and CHO (P450
reductase) were transfected with pSP189 vector DNA by the
calcium phosphate co-precipitation procedure (Kraemer and
Seidman. 1989). The transfected cells were grown in the medium
containing 30 jM BP-3.6-Q for 4 h. Forty-eight hours following,
the transfection. the shuttle vector DNA was rescued and the supF
tRNA gene analysed for mutation as described under the in vitro
mutation studies.
Hydroquinone carcinogenicity
Transforrnation ofBALBc/3T3 cells
The transformation of BALBc/3T3 cells by hydroquinone was
studied by a previously described procedure (Sakai et al. 1995).
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Table 1 Frequency of benzo(a)pyrene-3.6-hydroquinone (BP-3.6-HQ)- and benzoquinone hydroquinone (HOs)-induced deleton of a single cytosine from
sequence 5'-172-CCCCC-176-3' of the pSP189.
Sample Total mutation frequery Mutation frequency
per million transformantsa of deetion of a single
cytosine from sequence
5'-172-CCCCC-176-37/
million transformantsb
Cell-free systernr
pSP189 + DMSO 1.11 ±0.02 0.0
pSP189 + BP-3.6-Q 2.75 + 0.05 0.0
pSP189 + BP-3,6-0 + P450 reductase 5.95 0.39 0.0
pSP189 + BP-3.6-O + purified human NQO1 2.38 0.11 0.30 + 0.02
pSP189 + BP-3.6-0 + purified rat NOO1 2.11 + 0.17 0.37 _ 0.03
pSP189 + BP-3.6-O + punifed human NOO1
+ SOD (30U) + catalase (40U) 2.41 - 0.36 0.30 ±0.03
pSP189 + HO 2.28 + 0.41 0.18 ± 0.02
CHO cellsysterri
CHO (wild type) + pSP189 + DMSO 1.31 + 0.06 0.0
CHO (wild type) + pSP189 + BP-3,6-O 2.41 + 0.29 0.0
CHO (NO01) + pSP189 + DMSO 1.21 - 0.23 0.0
CHO (NO01) + pSP189 + BP-3,6- 2.40 ± 0.31 0.24 0.03
CHO (P450 reductase); + pSP189 + BP-3.6-O 5.71 - 0.69 0.0
aTotal mutation frequencies were determined by counting the number of mutant colonies observed per million transformants. The results are presented as mean
- s.e. of four independent experiments. -Total of 40 mutants were sequenced in each set. The results are presented as mean - s.e. of four independent
experiments. Note that mutational spectra other than deletion of a single cytosine in all the cases were similar to the spontaneous mutations and are shown in
Table 2.-Cell-free system. The plasmid pSP189 containing the mutational target supFtRNA gene was incubated with DMSO (spontaneous mutations) or
BP-3.6-0 (15 gM) in absence and presence of purified human and rat NQO1 (5 jg) and superoxide dismutase (SOD) and catalase as indicated. In related
experiments, the BP-3.6-0 was replaced with 15 gM HO. Hydroquinone-induced mutatins in the supFtRNA region were determined by procedures as
described in Materials and methods. The purified human and rat NO01 were obtained from Dr David Ross, School of Pharmacy, Denver. CO. USA. Both
human and rat NQO1 enzymes are known to catalyse high-affinity reducbon of BP-3, 6-0 to BP-3,6-HO. :CHO cell system. The Chinese hamster ovary (CHO)
cells (wild type) expressing endogenous levels of cytosolic NQO1 and microsomal P450 reductase and the CHO cells permanentty expressing either 1367-fold
higher level of cDNA derived cytosolic NQO1 (NO01) or 34-fold higher levels of cDNA derived microsomal P450 reductase (P450 reductase) were transfected
with pSP189 plasmid in separate experiments. The transfected cells were treated with DMSO (control) or with BP-3,6-O. NQO1 catalyses two-electron
reducton of BP-3.6-Q (quinone) to BP-3,6-HO (hydroquinone). P450 reductase catatyses one-electron reductive activation of BP-3,6-Q (quinone) to BP-3.6-SQ
(semiquinone) and ROS (reactive oxygen species). The metabolites thus generated bind to the plasmid pSP189, resutting in the formation of DNA adducts
leading to mutagenicity. Mutational spectra in each case was determined as described in the text.
Briefli-. BALBc/3T3 cells were grown as a monolaver in
Dulbecco's modified Eagle's medium (DMEM) contaimnng 10%
calf serum. One dav before the initiation oftransformation. 16 000
cells were plated per 100-mm Petri dish (40 plates per group). The
cells were allowed to grow in the medium containing 15 gNi
hydroquinone for 3 days. The medium was changed and the cells
were grown in fresh medium for 3 days. Subsequently. the cells
were grown in the medium containing 300 ng ml-' TPA for 2
weeks. during which period the medium was changed tmice
weeklv. The cells were allowed to grow in the control medium for
an additional 2 weeks and the individually growing transformed
foci (>3 mm size) were counted. It mav be noteworthv that not
more than one focus was visible per plate. Therefore. the xarious
foci selected by us represent independent clones of transformed
BALBc/3T3 cells and the question of siblings does not arise.
Growth ofnormal and HQ+TPA transformedBALBc/3T3
cells
A similar number of normal and HQ+TPA-transformed
BALBc/3T3 cells were plated in separate Petri dishes. The cells
were grown under similar (5c% CO,: 37 C) conditions. Four days
after growth. the cells were photographed and growth of normal
and transformed cells compared.
Subcutaneous injection ofHQ- and HQ+TPA-transformed
BALBc/3T3 cells and development oftumours in SCID mice
All the foci representing, xarious clones of HQ- and HQ+TPA-
transformed BALBc/3T3 cells were tested for their capacitx
to form tumours in SCID mice. In each case. 10xl0 cells in a
volume of 200 il growth medium were subcutaneouslx injected
into the SCID mice. Appropriate controls received either the
growth medium or the control BALBc/3T3 cells. The mice were
obserxed for the dexelopment of subcutaneous tumour at the site
of the injection for a period of4 w eeks.
Analysis ofp53 and Ha-ras genes in the transformed
BALBcI3T3 foci
The HQ- and HQ+TPA-transformed foci of the BALBc/3T3 cells
w-ere individually transferred into 24-w ell plates and further
expanded. Genomic DNA from the various foci was isolated by the
procedure as described (Laird et al. 1991). This DNA w-as used as
template to amplify the p53 (exons 5-8) and the Ha-ras (exons 1
and 2) genes using polyImerase chain reaction (PCR). Exons 5-8 of
the p53 tumour suppressor-gene were sequenced individually using
the exon-based primers under the conditions as described
(Goodrow et al. 1992). Exons 1 and 2 ofthe Ha-ras oncog'ene were
amplified as a single fragment bx a modification of the prexiously
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Table 2 Mutations of the SupFtRNA gene (pSP189-Ad293 cells)
pSP189 + pSP189 + pSP189 + pSP189+ pSP189 + pSP189+ pSP189+
DMSO BPO BPO + BPQ + BPQ + BPO + H0
Reductase HDTD HDTD + RDTD
SOD + Cataae
No. of colonies analysed 40 40 40 40 40 40 40
No. of mutants 40 40 40 38 40 40 38
Mutahons
Base substtutions
A-*C 2 3 4 3 3 1 3
A-iT 4 2 1 4 2 3 2
A--+G 2 3 2 0 1 2 2
C--A 1 4 2 2 1 1 2
C-iT 3 2 1 0 1 0 0
C---).G 2 3 2 2 2 2 2
T-iA 3 1 1 2 3 2 3
T--+C 3 2 1 2 1 3 1
T-iG 2 2 1 0 2 2 1
G--A 3 1 4 1 4 3 2
G-+C 2 3 3 2 1 2 2
G-iT 3 1 3 2 2 1 4
Deletions
A 1 2 1 2 2 1 2
C (Random) 0 0 3 2 2 3 2
C (172-CCCCC-176) 0 0 0 5 7 5 3
T 0 1 0 0 0 2 0
G 1 2 5 2 1 1 1
68-119 3 3 1 1 2 2 2
Insertions
A 1 0 0 1 0 1 0
T 0 0 1 1 0 0 0
Unclassified 4 5 4 4 3 3 4
Mutation frequencies of benzo(a)pyrene-3.6-quinone (BP-3.6-Q); benzo(a)pyrene-3.6-semiquinone + reactive oxygen species (BP-3,6-SQ + ROS) and
benzo(a)pyrene-3,6-hydroquinone (BP-3,6-HQ) in a cell-free system. The plasmid pSP189 containing the mutational target SupFtRNA was incubated with
DMSO (spontaneous mutations) or with COS1 cell extract expressing 68-fold higher levels of cDNA-derrved cytochrome P450 reductase (BP-3.6-semiquinone
+ ROS induced mutations) or with punfied human or rat NQ01 (hydroquinone-induced mutations). The experiment with purified NQ01 (hydroquinone
mutagenicity) was also performed in the presence of SOD and catalase. Mutations in each case were detected by the procedures as described in Materials and
methods. A total of 40 mutants was sequenced in each set. Frequency of mutations are shown per million transformants. HDTD. human DT diaphorase
(NO01): RDTD. rat DT diaphorase (NO01).
described procedure usina the primers and PCR conditions as
ci-en below (Colapietro et al. 1993):
Primer 1. 5'-ATCACAGAATACAAGC1TGTGG-3'
Primer 2. 5'-CTGTACTGATGGATGTCCTC-3'
The PCR conditions involved 30 cvcles of denaturation at 94-C
for 1 min. annealinrt at 58-C for 2 mn and extension at 72-C for
2 min follow-ed bv an extension of 7 min at 72'C.
The PCR products were analysed on 1 % agarose gel and sub-
cloned immediatelv into the PCR 2.1 vector of the TA clonin2 kit
(Invitrogen. San Diego. CA. USA) and used to transform compe-
tent E. coli cells according to the protocols of the manufacturer.
DNA was isolated from the transformants and sequenced using the
sequenase version 2.0 DNA sequencing kit. The primers used to
sequence the exon 1 and exon 2 of the Ha-ras gene w-ere the same
as reported (Colapietro et al. 1993).
RESULTS
The results on BP-3.6-HQ- and HQ-induced mutations from the
studies using a cell-free system are reported in Tables 1 and 2. The
spontaneous mutation frequency of pSP189 plasmid DNA treated
w-ith DMSO was 1.11±0.02 per million transformants in the cell-
free svstem and 1.31+0±06 per million transformants in the CHO
cell system (Table 1). The total mutation frequencies in both the
systems increased twofold in the presence of BP-3.6-Q. P450
reductase but not NQO1 further increased the total mutation
frequency by 2'5-fold as compared with BP-3.6-Q (Table 1).
Inclusion of superoxide dismutase and catalase (scavengers of
ROS) with NQO1 had no effect on total mutation frequency
obserxed with BP-3.6-Q + NQO1 (Table 1). Analysis of the muta-
tion spectra revealed that all the mutations except deletion of one
cytosine from the sequence 5'-172-CCCCC-3' were more or less
similar to the spontaneous (DMSO) mutations. It may be note-
worthy that hydroquinone-induced deletion of a single cytosine
may have been the result of deletion of a single guanosine in the
complementary strand. The deletion of cytosine from a stretch of
fixve cvtosines was not observed in spontaneous mutations and in
the mutations caused by quinone (BP-3.6-Q) and P450 reductase-
activated quinone BP-3.6-Q (BP-3. 6-semiquinone and reactive
oxygen species) (Figure 1. Tables 1 and 2. Howexer. the deletion
ofone cy-tosine from 5'-CCCCC-3' w-as observed w-ith BP-3.6-HQ.
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Figure 1 (A) Nucleotide sequence of supFtRNA gene in pSP189. Hot spot
for hydroquinone (HQ)-induced frameshift mutation invoMng deletion of a
single cytosine is indicated in bold letters. (B) Hydroquinone (HQ)-induced
deletion of a single cytosine from sequence 5'-CCGCC-3'. Left. DNA
sequence in 5'-i2' orientation. Note five Cs vs four Cs. Right, DNA sequence
in 3'-*5' orientation. Note five Gs versus four Gs
The mutation frequency ofdeletion of cytosine induced by BP-3.6-
HQ >-as 0.30 (12.6%- of total mutation frequencv) with human
NQOl enzxme and 0.37 ( 17.5%' of total mutation frequencyv with
rat NQOI enzxme per million transformants (Table 1). These
mutation frequencies of deletion of one c-tosine from fix-e
cyVtosines A-ere highlv significant because the background (sponta-
neous mutation) frequency w-as zero. The deletion of one cytosine
from the sequence 5'-CCCCC-3' A-as also specific to the hxdro-
quinones (BP-3.6-HQ) because similar mutations w-ere not
obserxed xxith quinones (BP-3.6-Q) and redox cycling products of
quinones (semiquinones + reactive oxy gen species). Interestingly.
the mutation frequency of deletion of cytosine remained more or
less unaffected in the presence of high amounts of purified super-
oxide dismutase (SOD) and catalase. the scaxvengers of reactixe
oxxgen species. A second hvdroquinone (benzoquinone HQ)
caused similar cytosine deletion mutations as BP-HQ at mutation
frequency of 0.18 per million transformants (Tables 1 and 2). The
nucleotide sequence of supF tRNA region of plasmid pSPl 89 and
the HQ-induced deletion of one cytosine from a stretch of fixve
cyVtosines are show n in Figure 1.
Similar results as described above with the cell-free svstem
A-ere also observed in in xvivo mutagenesis experiments as show-n
in Tables 1 and 3. The CHO (A-ild type) cells expressing, loxw
(endogenous) lexels of NQO 1 and P450 reductase. the CHO
INQOI cells permanently expressing 1367-fold higher lexels of
cDNA-derived human NQOO and the CHO (P450 reductase) cells
permanently expressing, 34-fold higher lexels of cDNA-deri-ved
human P450 reductase were transfected w-ith pSP189 plasmid
followed by treatment with BP-3.6-Q. Mutational spectra in each
case w-ere determined by standard procedures (Kraemer and
Seidman. 1989: Pairs and Seidman. 1992). The treatment of CHO
cells expressinc endogenous lexels of NQO1 and P450 reductase
Figure 2 Comparison of growth of normal and HQ+TPA-transformed
BALBc/3T3 cells. Three hundred normal and a similar number of HQ+TPA-
transformed cells were plated and grown under similar conditions. After four
days. the cells in Petn dishes were visualized under microscope and
photographed. (A) Normal (DMSO-treated) cells. (B) HQ+TPA-transformed
cells
and the CHO cells expressing high lexels of P450 reductase failed
to show the deletion of cvtosine from sequence 5'-172-
CCCCC176-3'. Howexver. the CHO cells expressing higher lexvels
of NQOI shovved deletion of a single cytosine at a frequency of
10%f of total mutations or mutation frequency of 0.24 per million
transformants.
Incubation of 0.64xl10 mouse BALBc/3T3 cells with benzo-
quinone hydroquinone (HQ) resulted in the transformation of
BALBc/3T3 cells and selection of a single cloned focus (Table 4).
Howex er. incubation of a similar number of BALBc/3T3 cells with
hydroquinone. followed by tumour promoter TPA. significantly
increased the number of transformed foci to 24 (Table 4). In the
same experiment TPA alone failed to generate any foci. The 24 foci
selected with hy-droquinone+TPA treatment grew 10-20 times faster
than normal (untransfonned) BALBc/3T3 cells and lost contact
inhibition. as demonstrated in Figure 2. These results also indicated
that hydroquinones may function as initiators of carcinouenesis and
require a promoter (e.g. TPA) for cellular transformation and prolif-
eration. It may be noteworthv that in a similar experiment. 3-methyl-
cholanthrene (3-MC) also transformed BALBc/3T3 cells and
produced 22 foci (Table 4 legend). Inclusion of TPA in the experi-
ment increased the number of3-MC induced foci to 47.
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Table 3 Mutations of the SupFtRNA gene (pSP 189 - CHO celts)
CHO (W) + CHO (W) + CHO (NQO01) + CHO (NQO01) CHO (RED) +
pSP189 + DMSO pSP189 + BPQ pSP189 + DMSO pSP189 + BPQ pSP189 + BPO
No. of coloniesanalysed 40 40 40 40 40
No. of mutants 40 40 38 40 40
Mutations
Base substitutions
A-iC 4 2 3 3 2
A-iT 3 4 2 3 1
A--+G 3 1 2 2 3
C--iA 1 3 3 2 2
C-iT 2 1 2 1 2
C-iG 2 2 3 2 2
T-A 3 3 2 3 2
T-iC 3 3 2 1 1
T--+G 2 4 2 3 2
G-iA 4 2 1 3 3
G-iC 2 1 2 0 3
G-iT 3 2 3 2 1
Deletions
A 1 3 2 3 4
C (Random) 0 1 0 2 0
C (172-CCCCC-176) 0 0 0 4 0
T 0 0 2 0 1
G 2 1 1 0 6
68-119 2 2 3 4 2
Insertions
A 0 1 0 0 0
C 0 0 0 0 1
Undassified 3 4 3 2 2
Mutation frequencies of benzo(a)pyrene-3.6-quinone (BP-3.6-Q). benzo(a)pyrene-3.6-hydroquinone (BP-3,6-HQ) and benzo(a)pyrene-3.6-semi-
quinone + reactive oxygen species (BP-3,6-SQ + ROS) as determined by using CHO cell system. The Chinese hamster ovary (CHO) cells (wild type), CHO
cells expressing 1367-fold higher levels of cDNA-denved human N001 and CHO cells expressing 68-fold higher levels of cytochrome P450 reductase were
transfected with plasmid pSP189. The transfected cells were treated with either DMSO (control) or benzo(a)pyrene-3,6-quinone (BP-3.6-O). The mutational
spectra generated due to DMSO (spontaneous) and metabolites of BP-3.6-Q were determined by procedures as descnbed in Materials and methods. Mutation
frequencies are shown per million transformants.
Interestingiv. all ofthe 24 BALBc/3T3 foci selected w-ith hvdro-
quinone+TPA produced subcutaneous tumours in SCID mice
(Figure 3). Tw-enty per cent of the hN-droquinone+TPA-trans-
formed foci grewx ver- fast and tumours became visible after 1
week. In the remaining 80%e of cases. the tumours were xisible
betw een 2 and 4 weeks. A single hydroquinone-transformed
colonx of BALBc/3T3 cells also produced tumours in SCID mice
that were visible after 4 weeks of injection. Under similar condi-
tions. control BALBc/3T3 cells did not produce tumours in SCID
mice in 24 weeks of our observation.
DISCUSSION
In this report. w-e demonstrate that hxdroquinones of
benzo(alpyrene quinones and benzoquinones (BP-HQ and HQ)
are mutagenic compounds. Mutagenesis experiments clearly indi-
cate that BP-HQ and HQ both cause sequence-specific deletion of
a sinale cvtosine from a group of five cytosines or a single guano-
sine from a group of fixve guanosines in the complementary strand.
resulting in frameshift mutations. This type of frameshift mutation
was not detected in spontaneous mutations. mutations caused by
quinones or mutations generated by semiquinones and reactive
oxygen species. t-0o important products of the redox cycling of
Figure 3 Hydroquinone-induced subcutaneous tumours. Groups of ten
mice were subcutaneously injected with either control (normal) BALBc/3T3
cells or HO-and HQ+TPA-transformed BALBc/3T3 cells. Each mouse
received ten million cells in growth medium. The mice were observed for the
development of subcutaneous tumours at the site of injection. Mice injected
with control (normal) cells did not produce tumours as shown on the left. Mice
injected with hydroquinone +TPA produced fast-growing tumours as shown
on the right. The position of the tumour in the mouse on the right side is
indicated by an arrow. Twenty out of 24 hydroquinone+TPA-transformed
BALBc./3T3 foci produced fast-growing tumours in SCID mice. The remaining
four hydroquinone+TPA- and a single hydroquinone-transformed BALBcI3T3
foci produced slow-growing tumors. which became visible after 8 weeks (data
not shown)
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Table 4 Hydroquinone-induced transfornation of BALBct3T3 celLsa
Chemical Number offoc
Ethanol 0
HO 1
HQ+ TPA 24
TPA 0
a0.64x1loe BALBc/3T3 cells were plated at adensity of 16000 cells in
100 mm Petri dishes. The cells were exposed for 72 h eiter to 15gu
benzoquinone hydroquinone (HtQ) or to ethanol, used as the solvent to
dissolve hydroquinone. The cells were washed and alowed to grow in the
control medium for 3 days. Subsequently, the cels were exposed either to
12-O-tetradecanxyphrbol-13-acetate (TPA, 300 ng mt-' of the medium) or to
acetone (the solvent used to dissolve TPA) for 2 weeks. The cells were
washed to remove TPA and were allwed to grow for an additonal 2 weeks in
the contrd medium. The foci developed were scored, isoated and expanded
ikvkidually. Under similar experimental condibons as described above,
3-methycholanthrene (34MC) produced 22 foci with 34MC alone and 47 foci
with 3-MC + TPA treatment
quinones. We further demonstrated that BP-HQ-induced deletion
ofa single cytosine from sequence 5'-CCCCC-3' was not mediated
by reactive oxygen species generated by oxidation ofBP-HQ. This
is because the mutation frequency ofdeletion of a single cytosine
was not affected by SOD and catalase. well-known scavengers of
the reactive oxygen species. It is expected that BP-HQ may
directly alkylate the DNA at specific sites containing a stretch of
five cytosines or five guanosines leading to deletion of a single
cytosine or guanosine by an unknown mechanism.
Several observations indicate that DNA sequences containing
5'-CCCCC-3' or 5'-GGGGG-3' serve as hot spots for BP-HQ and
HQ binding and mutagenicity. Firstly, the only mutation detected
with BP-HQ and HQ above the level of spontaneous mutations
was deletion of a single cytosine from sequence 5'-CCCCC-3'.
The stretch of four cytosines and guanosines within the supF
tRNA region was not targeted by BP-HQ and HQ. Secondly. two
different hydroquinones (BP-HQ and HQ) showed similar muta-
tions involving deletion of a single cytosine with significant
frequencies (Table 1). Lastly. hydroquinone-induced deletion of
C from sequence 5'-CCCCC-3' was not detected in spontaneous
mutations and in mutations induced by unmetabolized quinones
and P450 reductase-activated products ofquinones (semiquinones
and reactive oxygen species).
The HQ treatment of BALBc/3T3 cells resulted in cellular
transformation. which was significantly increased by tumour-
promoting agents (TPA). The hydroquinone + TPA-transformed
BALBc/3T3 cells produced fast-growing tumours in SCID mice.
These results suggested that hydroquinones possess initiating
capacity and require tumour promoters for complete transfonna-
tion of cells leading to the development of fast-growing tumours.
The various results also suggest thathydroquinone possesses much
weaker initiating activity than 3-MC.
Figure 4 Model for benzo(a)pyrene hydroquinone and benzoquinone hydroquinone mutagenicity and carcinogenicity. Benzo(a)pyrene quinones and
benzoquinones eiterdirectly or after reductive metabolism by P450 reductase into products (semiquinones and reactive oxygen species) bind with the DNA
and cause mutations. On the other hand, NO01 comnpetes with P450 reductase and catalyses theformaion of hydroquinones. It may be noteworthythat
sefmiunones generated dunng P450 reductase-stmulated redoxcycig may also be converted to hydroquinone by a secondeectron reducton. This is
especialy the case in the absence of oxygen. Hyroquinones corjuate with UDP-gucuronic acid,giutathn and suphate, leading to theirexcretion from the
cells. The variou conjugation reacbons are catalysed by UDPG-bansferase (UDPGT), gutathione S-transferase (GST) and su4hotransferase (ST). Therefore,
the NOO1 pathway protects the cells from adverse effects ofsemiqum re and reactive oxygen species by preventing theirformation. However, hydroquinones
produced during the metaboic reducto of quaioies by N001, if notconqugated withglutthione orUDP-lucuronic acid and excreted from the cells, cause
frameshift mutabons involvi deleton of a sxgle cytosine from sequence 5'-CCCCC-3. This type ofmutaton was not observed with quinones, semiquinones
and reactve oxygen species. Therefore, the delebon muttion of asingle cytosine from sequence 5'-CCCCC-3' isspecificaly associated with hydroquinones.
In addition, the hydroquinones in assocation with tumour promoterstransformed normal cells to malignant ceNs leading to tumourfornation
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Based on previous studies and results presented in the present
report. a model to demonstrate the generation. detoxification and
mutagenicity/carcinogenicity ofhydroquinones ofbenzo(a)pyrene
quinones and benzoquinones is presented in Figure 4.
Hydroquinones are generated by two-electron reduction of
quinones catalysed by NQO1. They are more stable than the semi-
quinones. They conjugate with glutathione and UDP-glucuronic
acid, leading to their excretion from the cells (Lind et al. 1982).
Therefore. the generation of hydroquinones within cells is a
mechanism to protect them from the adverse effects of quinone
exposure. Paradoxically. hydroquinones are mutagenic and
carcinogenic as demonstrated in the present study. Hydroquinones
caused sequence-specific frameshift mutations involving the dele-
tion ofa single cytosine from the sequence 5'-CCCCC-3'. In asso-
ciation with tumour promoters, hydroquinones transformed the
cells with high efficiency and led to development offast-growing
tumours. These results with hydroquinones raised three important
questions: (1) how safe is it to detoxify quinones by its conversion
to hydroquinones mediated by NQO1: (2) are all the hydro-
quinones mutagenic and carcinogenic: and (3) which growth regu-
latory genes are mutated by HQ resulting in fast-growing tumours
in SCID mice.
In response to the first question. it appears to be quite safe to
detoxify quinones by NQO1-mediated conversion of quinones to
hydroquinones. provided hydroquinones are removed by conjuga-
tion reactions as shown in the model in Figure 4. This is also
supported by the fact that chemopreventive agents (e.g. antioxi-
dants and vitamins) not only induce the expression of the NQOI
gene but also coordinately induce the expression ofhydroquinone
conjugating enzymes. glutathione S-transferase and UDPG-trans-
ferase (Rushmore and Pickett. 1993: Jaiswal. 1994). However. this
scenario could be very different in cases in which the expression of
conjugating enzymes is lost or lowered as a result of mutations.
etc. The question regarding mutagenicity of various kinds of
hydroquinones will require further study. Based on theirring struc-
tures, three different kinds ofhydroquinones have been suggested
(Cadenas. 1995). These include: (1) redox-stable hydroquinones:
(2) redox-labile hydroquinones that subsequently auto-oxidize to
generate reactive oxygen species: and (3) hydroquinones that
rearrange to potent electrophiles resulting in alkylation of DNA.
Because BP-3.6-HQ-induced mutations were unaffected by scav-
engers of reactive oxygen. the hydroquinones of benzo(a)pyrene
quinones and benzoquinones used in the present studies may
belong to the first and third category. The identification of genes
targeted by HQ will also require additional work. A high
percentage of tumours is known to arise from chemically induced
frameshift mutations. as well as base substitutions. in a number of
oncogenes and tumour-suppressor genes (Balmain and Brown.
1988: Hollstein et al. 1991; Beroud et al. 1996). Thirty-seven per
cent ofhuman p53 mutations are caused by deletion and insertion
of bases leading to frameshift mutations (Hollstein et al. 1991).
Similarly the Ha-ras gene has been shown to be the target of
chemical mutations (Harris. 1991). Therefore. we sequenced the
p53 (exons 5-8) and Ha-ras (exons 1-2) genes in all 24 of the
hydroquinone+TPA-transformed and one hydroquinone-trans-
formed foci. The sequencing results failed to show any kind of
(base substitution and/or insertion ordeletion) mutation in thep53
and Ha-ras genes in these foci, indicating that some othergrowth-
regulatory genes may be involved. A search ofthe GenBank data-
base for the presence of a hydoquinone specific sequence
5'-CCCCC-3' revealed that a large number of genes contain this
sequence. Therefore. it is difficult to predict which genes may
have been mutated in hydroquinone-transformed cells and
tumours. Future experiments are required to identify these genes
and to determime ifmutations are due to the deletion ofcytosine.
In conclusion. we have shown that: (1) environmentally abun-
dant hydroquinones of benzo(a)pyrene quinones and benzo-
quinones cause specific mutations involving deletion of one
cytosine from DNA sequence 5'-CCCCC-3' or one guanosine
from the sequence 5'-GGGGG-3': (2) hydroquinones function as
initiators ofcarcinogenesis: (3) hydroquinones in association with
tumour promoters transform normal cells to malignant cells
leading to fast-growing tumours; and (4) benzo(a)pyrene and
benzene carcinogenicity may be due in part to their hydroquinone
metabolites.
ABBREVIATIONS
NQOI. cytosolic NAD(P)H:quinone oxidoreductase 1 or DT
diaphorase: P450 reductase. microsomal NADPH:cytochrome C
reductase: SOD, superoxide dismutase: BP. benzo(a)pyrene:
BPQ. benzo(a)pyrene quinone; BP-3.6-Q. benzo(a)pyrene-3.6-
quinone: BP-3.6-SQ. benzo(a)pyrene-3.6-semiquinone; BP-3.6-
HQ. benzo(a)pyrene-3.6-hydroquinone: BQ. benzoquinone: HQ.
benzoquinone hydroquinone: ROS. reactive oxygen species.
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